Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Price to Cash Earnings (PCE)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   PCE(x) 7.707.08-6.31--

What is the latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) ?

The latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) is 7.70 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20247.70
Mar20237.08
Mar2022-6.31
Mar2013-
Mar2012-

How is Price to Cash Earnings (PCE) of NATH BIOGENES (INDIA) Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 7.7
8.76
Mar2023 7.08
Positive
Mar2022 -6.31
0
Mar2013 0
0
Mar2012 0 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Price to Cash Earnings (PCE) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹377.2 Cr -2.4% 5.6% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,934.7 Cr -5.8% -6.3% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹6,436.8 Cr -5.7% -15.3% 32.9% Stock Analytics
VENKYS (INDIA) ₹2,264.3 Cr -1.5% 0.4% -16.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,435.5 Cr -2% -1.8% -33.7% Stock Analytics
INDO US BIOTECH ₹307.9 Cr 1.5% 1.6% -27% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.4%

5.6%

-1%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses